Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 119

1.

Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry.

Gitt AK, Bramlage P, Potthoff SA, Baumgart P, Mahfoud F, Buhck H, Ehmen M, Ouarrak T, Senges J, Schmieder RE; EARLY Registry Group.

BMC Cardiovasc Disord. 2016 Mar 8;16(1):56. doi: 10.1186/s12872-016-0222-6.

2.

The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.

Bramlage P, Schmieder RE, Gitt AK, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Potthoff SA; EARLY Registry Group.

Trials. 2015 Dec 19;16:581. doi: 10.1186/s13063-015-1100-8.

3.

Factors Associated With Cardiovascular Events in Patients With Type 2 Diabetes and Acute Myocardial Infarction.

Strojek K, Raz I, Jermendy G, Gitt AK, Liu R, Zhang Q, Jacober SJ, Milicevic Z.

J Clin Endocrinol Metab. 2016 Jan;101(1):243-53. doi: 10.1210/jc.2015-1962. Epub 2015 Nov 23.

PMID:
26595100
4.

Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany.

Gitt AK, Sonntag F, Jannowitz C, Weizel A, Karmann B, Schaefer JR, Pittrow D, Hildemann SK.

Curr Med Res Opin. 2016 Mar;32(3):417-26. doi: 10.1185/03007995.2015.1120715. Epub 2015 Dec 29.

PMID:
26568400
5.

Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus.

Tschöpe D, Bramlage P, Schneider S, Gitt AK.

Diab Vasc Dis Res. 2016 Jan;13(1):2-12. doi: 10.1177/1479164115610470. Epub 2015 Nov 12.

PMID:
26567123
6.

The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry.

Agnelli G, Gitt AK, Bauersachs R, Fronk EM, Laeis P, Mismetti P, Monreal M, Willich SN, Wolf WP, Cohen AT; PREFER in VTE investigators.

Thromb J. 2015 Oct 21;13:41. doi: 10.1186/s12959-015-0071-z. eCollection 2015.

7.

Use and outcome of thrombus aspiration in patients with primary PCI for acute ST-elevation myocardial infarction: results from the multinational Euro Heart Survey PCI Registry.

Weipert KF, Bauer T, Nef HM, Möllmann H, Hochadel M, Marco J, Weidinger F, Zeymer U, Gitt AK, Hamm CW.

Heart Vessels. 2015 Oct 5. [Epub ahead of print]

PMID:
26438532
8.

Fate of Patients With Coronary Perforation Complicating Percutaneous Coronary Intervention (from the Euro Heart Survey Percutaneous Coronary Intervention Registry).

Bauer T, Boeder N, Nef HM, Möllmann H, Hochadel M, Marco J, Weidinger F, Zeymer U, Gitt AK, Hamm CW.

Am J Cardiol. 2015 Nov 1;116(9):1363-7. doi: 10.1016/j.amjcard.2015.07.056. Epub 2015 Aug 14.

PMID:
26341189
9.

Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort.

Hartmann B, Bramlage P, Schneider S, Tschöpe D, Gitt AK.

Acta Diabetol. 2015 Dec;52(6):1093-101. doi: 10.1007/s00592-015-0794-0. Epub 2015 Aug 5.

PMID:
26239142
10.

Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry.

Schmieder RE, Potthoff SA, Bramlage P, Baumgart P, Mahfoud F, Buhck H, Ouarrak T, Ehmen M, Senges J, Gitt AK; EARLY Registry Group.

J Clin Hypertens (Greenwich). 2015 Dec;17(12):947-53. doi: 10.1111/jch.12603. Epub 2015 Jun 24.

11.

Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry.

Schmieder RE, Gitt AK, Koch C, Bramlage P, Ouarrak T, Tschöpe D; DIALOGUE study group.

BMC Endocr Disord. 2015 May 2;15:23. doi: 10.1186/s12902-015-0020-7.

12.

Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology.

Heer T, Hochadel M, Schmidt K, Mehilli J, Zahn R, Kuck KH, Hamm C, Böhm M, Ertl G, Andresen D, Massberg S, Senges J, Pilz G, Gitt AK, Zeymer U.

Clin Res Cardiol. 2015 Jun;104(6):507-17. doi: 10.1007/s00392-015-0815-6. Epub 2015 Jan 21.

PMID:
25875945
13.

A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy.

Gitt AK, Bramlage P, Schneider S, Tschöpe D.

Cardiovasc Diabetol. 2015 Feb 3;14:13. doi: 10.1186/s12933-015-0172-9.

14.

Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.

Bramlage P, Gitt AK, Schneider S, Deeg E, Tschöpe D; DiaRegis Study Group.

BMC Cardiovasc Disord. 2014 Nov 19;14:162. doi: 10.1186/1471-2261-14-162.

15.

[Antithrombotic treatment in patients with stable coronary artery disease. Which drugs and for how long?].

Gitt AK, Zahn R.

Herz. 2014 Nov;39(7):798-802. doi: 10.1007/s00059-014-4171-5. German.

PMID:
25361793
16.

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.

Crijns HJ, Weijs B, Fairley AM, Lewalter T, Maggioni AP, Martín A, Ponikowski P, Rosenqvist M, Sanders P, Scanavacca M, Bash LD, Chazelle F, Bernhardt A, Gitt AK, Lip GY, Le Heuzey JY.

Int J Cardiol. 2014 Apr 1;172(3):588-94. doi: 10.1016/j.ijcard.2014.01.099. Epub 2014 Jan 25.

17.

Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).

Lip GY, Gitt AK, Le Heuzey JY, Bash LD, Morabito CJ, Bernhardt AA, Sisk CM, Chazelle F, Crijns HJ; RHYTHM-AF Scientific Committee.

Am J Cardiol. 2014 Feb 1;113(3):480-4. doi: 10.1016/j.amjcard.2013.10.036. Epub 2013 Nov 9.

PMID:
24332698
18.

Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.

Bauer T, Gitt AK, Hochadel M, Möllmann H, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J, Zeymer U.

Int J Cardiol. 2013 Oct 15;168(6):5239-42. doi: 10.1016/j.ijcard.2013.08.024. Epub 2013 Aug 14.

PMID:
23998547
19.

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL.

Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30. No abstract available. Erratum in: Eur Heart J. 2014 Sep 1;35(33):2260-1.

20.

Prognostic implications of DPP-4 inhibitor vs. sulfonylurea use on top of metformin in a real world setting - results of the 1 year follow-up of the prospective DiaRegis registry.

Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.

Int J Clin Pract. 2013 Oct;67(10):1005-14. doi: 10.1111/ijcp.12179. Epub 2013 Aug 28.

PMID:
23981060
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk